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Abstract
Background: Traditional Chinese Medicine (TCM) has been applied in treating tuberculosis (TB) based on the TCM
syndromes with the effects of inhibiting Mycobacterium, strengthening the body immune system, and reducing
the pulmonary toxicity. We used bioinformatic methods to study the clinical and pathological characteristics of
pulmonary TB patients with TCM syndromes. Isobaric tags for relative and absolute quantification - coupled two
dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) methods were applied to
screen differentially expressed serum proteins.
Methods: Pulmonary TB cases were divided into four distinctive TCM syndromes: pulmonary Yin deficiency (PYD)
syndrome, hyperactivity of fire due to Yin deficiency (HFYD) syndrome, deficiency of Qi and Yin (DQY) syndrome,
and deficiency of Yin and Yang (DYY) syndrome. The serum samples from 214 pulmonary TB patients were
collected, and the clinical and pathological data was analyzed by using iTRAQ-2DLC-MS/MS. Finally, the differentially
expressed proteins were screened and tested by ELISA. Only 5 patients with DYY syndrome were recruited in
3 years, which were not enough for further research.
Results: The DQY cases had higher erythrocyte sedimentation rate (ESR) compared to the PYD and HFYD cases
(P = 0.0178). 94.44 % (12 PYD, 18 HFYD, and 4 DQY before anti-TB treatment) of 36 treated TB cases were transformed
to PYD accompanied with the reduction of ESR and absorption of pulmonary lesions. A total of 39 differentially
expressed proteins (ratios of >1.3 or <0.75) were found among the three TCM syndromes. Proteomic studies revealed
that gamma-glutamyl hydrolase (GGH), Ig gamma-3 chain C region (IGHG3), and haptoglobin (HPT) were specifically
over-expressed in PYD (P < 0.01), HFYD (P < 0.001), and DQY cases (P < 0.01), respectively. Furthermore, GGH was
significantly higher in PYD cases compared to the HFYD and DQY cases (P < 0.01, P < 0.001, respectively), whereas
IGHG3 was significantly higher in HFYD cases than PYD and DQY cases (P < 0.001, P < 0.01, respectively).
Conclusions: The results suggest that TCM syndromes are significantly correlated with the pulmonary lesions and ESR.
GGH was associated with folate metabolism in PYD cases, IGHG3 was linked to the control of Mycobacterium infection
in HFYD patients, and HPT was involved in hypoxia in DQY patients. The present study provides new biological basis to
understand the pathological changes and proteomic differences of TB syndromes.
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Background
Tuberculosis (TB) ranks as the second leading cause of
death from an infectious disease, just after the AIDS.
There were 8.6 million new TB cases and 1.3 million
deaths including 0.3 million deaths from HIV-associated
TB in 2012, globally [1]. The routine Western medicine
for TB treatment has to last at least for 6 months, and
may lead to drug-resistant TB [2] and severe hepatic side
effect [3–5]. Traditional Chinese Medicine (TCM) has
been applied in treating TB [6] based on the effects of
inhibiting Mycobacterium, strengthening the body im-
mune system, and reducing the pulmonary toxicity and
drug-resistant. Chinese herbs such as Gentiana rho-
dantha Franch [7], Astragalus membranaceus [8], and
Radix Paeoniae Rubra (Chishao) [9] have been described
to be medicinally used for the treatment of TB. Other
Chinese herbs such as Radix Ranunculi Ternati, Radix
Sophorae Flavescentis, Prunella Vulgaris L. and Stellera
Chamaejasme L. have been demonstrated to be effective
in treating multi-drug resistant (MDR)-TB [6, 10]. These
Chinese herbal medicines have either heat clearing and
detoxifying or nourishing Yin and reducing fire effects.
Biological researches revealed that Astragalus membra-
naceus extracts can strongly promote the phagocytosis
of Mycobacterium [8]. Radix Paeoniae Rubra extracts
can inhibit interleukin (IL)-10, and increase IL-8 in
BCG-activated primary human blood macrophages [9].
IL-8 can attract T lymphocytes and neutrophils to the
infection sites promoting the formation of granuloma at
the early stage of Mycobacterium infection, and acti-
vating bactericidal response from neutrophils [11–13].
IL-10 is an anti-inflammatory cytokine produced by
macrophages and T-cells during Mycobacterium infec-
tion [14]. Mycobacterium evades the host immunity with
the help of IL-10 [15–17]. Radix Paeoniae Rubra ex-
tracts has been shown to inhibit the expression of IL-10,
and can reduce the reactivation of TB and higher myco-
bacterial burden [18], thereby reducing the susceptibility
to Mycobacterium infection [19]. However, the Radix
Sophorae Flavescentis, Radix Ranunculi Ternati, Stellera
Chamaejasme L. and Prunella Vulgaris L. extracts en-
hance cell-mediated immunity in multidrug resistant
(MDR)-TB [10]. All these herbs can inhibit Mycobacter-
ium and strengthen the body immune system.
The herbs in a TCM prescription for patients depend
on the TCM syndrome differentiation [20]. Choosing
suitable herbs and dosages according to the TCM syn-
dromes differentiation would also improve the efficacy
and reduce the toxic effects of anti-TB drugs [21, 22].
TCM syndrome, also called Zheng, is a temporary state
at a period of time defined by symptoms, pulse feelings
and tongue appearance [23]. The same disease can be
classified into different syndromes. Differing from the
Western medicine, the diagnosis of TCM syndrome is
based on differentiation/classification [20]. TCM syndrome
is assessed by inspection, auscultation, olfaction, interroga-
tion, and palpation [20, 24]. Pulmonary TB patients were
mainly divided into four TCM syndromes: pulmonary Yin
deficiency (PYD) syndrome, hyperactivity of fire due to Yin
deficiency (HFYD) syndrome, deficiency of Qi and Yin
(DQY) syndrome, and deficiency of Yin and Yang (DYY)
syndrome [25]. Yin-Yang (two interdependent, opposite,
complementary, and exchangeable aspects of nature) have
been employed by ancient Chinese scholars to analyze pul-
monary TB [24]. Yin often refers to the material aspects of
the organism, and Yang refers to function. In addition, Qi
is another vital substance in TCM which has the function
of promoting blood circulation in the body [24].
Disease occurs when the balance or harmony of Yin –
Yang is disturbed [24]. PYD is the first stage of pulmon-
ary TB, and the patients who have PYD syndrome can
be characterized by Yin deficiency signs such as thirst,
tussiculation, mild night sweat, and feverishness in
palms and soles [25, 26]. HFYD is the second stage of
pulmonary TB, and the patients who have HFYD syn-
drome can be characterized by Yin deficiency and fire
hyperactivity signs such as steaming sensation in the
bone, dysphoria with feverish sensation in chest, palms
and soles [25, 26]. DQY is the third stage of pulmonary
TB, and the patients are characterized by Yin and Qi de-
ficiency signs such as weak and pale look. DYY is the
last stage of the disease, and the patients who have DYY
syndrome are almost in dead condition [25, 26].
However, criticism and skepticism was raised because the
principles of TCM are rooted from ancient Chinese phil-
osophy (Confucianism and Taoism), and syndrome differ-
entiation depends heavily on subjective observation, clinical
experience, and knowledge of practitioners with the lack of
scientific researches and objective tests [24]. The current
study employed bioinformatic methods (one-way ANOVA
and χ2 test) to investigate clinical and pathological changes
of the TCM syndromes of pulmonary TB, and to analyze
the syndrome transformation after treatment. Isobaric tags
for relative and absolute quantification (iTRAQ) - coupled
with two dimensional liquid chromatography-tandem mass
spectrometry (2DLC-MS/MS) was used to screen the spe-
cifically expressed serum proteins of pulmonary TB pa-
tients with distinctive TCM syndromes.
Our study is the first to analyze the pathological char-
acteristics and proteomic differences of pulmonary TB
in different TCM syndromes. We also provide solid
pathological background and biological evidence for the
TCM diagnosis.
Methods
The present study was approved by the Medical Ethics
Committee of Zhejiang University (China) and written in-
formed consent was obtained from all the blood donors.
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Patients and control subjects
The experimental design is illustrated in Fig. 1. A total
of 214 pre-treated pulmonary TB cases (aged 18 to
75 years) and 36 TB-treated cases (aged 20 to 67 years)
from the Sixth Hospital of Shaoxing (Shaoxing, Zhejiang,
China) were included in the study. However, there were
not enough DYY cases to be included in the investiga-
tion. In addition, 62 randomly chosen healthy blood do-
nors, aged from 22 to 65 years, from the Zhejiang
Hospital (Zhejiang, China) with no history of TB and
other diseases were also included (Table 1).
All pre-treated TB patients meet one of the following
diagnostic criteria: 1. Positive sputum culture or smear;
2. Typical active TB findings on Chest X-ray and CT
scan; 3. Pulmonary pathological lesions diagnosed as TB.
Meanwhile, subjects with extra-pulmonary TB, diabetes,
hepatitis B, AIDS and other diseases as well as immune
inhibitor users were eliminated from the study. Accord-
ing to the “Standard of disease diagnosis and curative ef-
fect of Traditional Chinese Medicine”, all the cases were
divided into PYD, HFYD, DQY, and DYY syndromes.
Clinical and pathological analysis
Clinical data such as sputum culture and smear, tuber-
culin test, smoking history, BCG inoculation rate, ESR,
blood coagulation, blood glucose level and pulmonary
CT findings of PYD, HFYD, and DQY patients are
shown in Table 2. The differences between PYD, HFYD,
and DQY cases were analyzed by one-way ANOVA fol-
lowing Tukey post-hoc test and χ2 test using GraphPad
Prism software. The transformation of TCM syndromes
was also investigated after treatment.
Serum collection and abundant protein depletion
Serum samples were collected in the vacuum tube with-
out anticoagulation and centrifuged at 3000 rpm for
10 min at 4 °C. 10 serum samples from PYD, HFYD,
DQY cases and healthy controls were mixed with the kit
column (Agilent multiple affinity removal column LC
column-14, the human MARS, Agilent, USA) to remove
14 highly abundant proteins, including albumin, IgG,
antitrypsin, IgA, transferring, haptoglobin, fibrinogen,
alpha 2-macroglobulin, alpha1-acid glycoprotein, IgM,
apolipoprotein AI, apolipoprotein AII, complement C3,
and transthyretin.
Protein enzymolysis and iTRAQ labeling
The specimens were isotope-labeled according to the
iTRAQ kit instructions (Applied Biosystem, Foster city,
CA, USA). 100 μg of the samples from each group was
mixed with pre-cooled acetone, and the pellet was dis-
solved with dissolution buffer and 1 % SDS. The reduced
samples were alkylated and digested by trypsin (Sigma,
St. Louis, MO, USA) overnight at 37 °C. Then the
digested samples were iTRAQ labeled. The 113, 118,
119 and 121 isobaric tags were used to label the healthy
controls, PYD, HFYD and DQY samples, respectively for
1 h at room temperature. The samples were obtained by
vacuum centrifugal concentration (Christ RVC 2 to 25,
Christ, Osterode, Germany) [27].
Fig. 1 Schematic diagram of the experiment. a Diagnosed pulmonary TB patients were divided into four distinctive TCM syndromes (the number
of DYY cases were insufficient for the experiment). The serum was collected, and the clinical and pathological characteristics were analyzed. b
After removing abundant proteins, samples were denatured, alkylated, digested, and labeled with the iTRAQ tags as follows: healthy controls-113
isobaric tag, PYD syndrome-118 isobaric tag, HFYD syndrome-119 isobaric tag, DQY syndrome-121 isobaric tag. Samples were then separated and
analyzed by 2DLC-MS/MS system, and differentially expressed proteins were further analyzed by ELISA and one-way ANOVA
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2D LC-MS/MS
The labeled samples were processed by Sep-Pak Vac C18
(Waters, Massachusetts, MA, USA) to remove the label-
ing reagent and salt. The labeled peptides were separated
with strong cation exchange liquid chromatography col-
umn (2.1 mm × 100 mm, 5 μm, 200 A, Polysulfoethyl
column, SCX) (Nest Group, Southborough, MA, USA).
Buffer A (10 mM KH2PO4, 25 % ACN, PH2.6) and a lin-
ear gradient 0 %-80 % of buffer B (10 mM KH2PO4,
350 mM KCL, 25 % CAN, pH 2.6) was used to separate
the samples at the flow rate of 200 μL /min for an hour
[28]. A total of ten gradient fractions were collected for
vacuum centrifugal concentration based on the peak
type and time.
The samples were dissolved and loaded into the ZOR-
BAX 300SB-C18 column (5 μm, 300 Å, 0.1 × 150 mm,
Microm, Auburn, CA, USA). Each fraction was analyzed
by Triple TOF 5600 system (Applied Biosystems) twice
and exported as run 1, and run 2. The mass spectra were
acquired by using positive ion mode and information-
dependent acquisition mode (IDA). In IDA mode, survey
scans were acquired between 400 to 1500 m/z, with up
Table 1 Characteristics of TB cases, treated-TB cases and healthy controls
TB cases Treated-TB cases Healthy controls P value
(N = 214) (N = 36) (N = 62)
Age, Age range (Mean ± SD) 18-75 (45.11 ± 15.08) 20-67 (44.33 ± 13.84) 22 − 65 (43.19 ± 8.84) 0.6337a
Gender (female: male) 72/142 10/26 30/32 0.8742b
Abnormal chest radiograph, no. (%) 214 (100) 2 (5.56) ND /
Positive sputum smears, no. (%) 152 (71.03) 0 ND /
BCG vaccination, no. (%) 196 (91.59) 28 (82.35) 57 (91.94) 0.984b
Smoking, no. (%) 97 (45.33) 16 (44.44) ND /
HIV-negative, no. (%) 214 (100) 36 (100) 62 (100) /
aP-value between TB cases, treated-TB cases, and healthy controls, for one-way ANOVA
bP-value between TB cases, treated-TB cases, and healthy controls for χ2 test
N: number of subjects; ND: not determined
Table 2 Characteristics of TB cases with PYD, HFYD and DQY Syndromes
PYD (N = 71) HFYD (N = 79) DQY (N = 64) P value
Age, Age range (Mean ± SD) 18-75 (43.36 ± 14.62) 18-75 (45.18 ± 15.08) 18-75 (46.78 ± 14.44) 0.4051a
Gender (female: male) 24/47 27/52 21/43 0.9924b
Positive sputum smears, no. (%) 50 (70.42) 53 (67.09) 49 (76.56) 0.4619b
Tuberculin skin test (>10 mm), no. (%) 40 (56.34) 47 (59.50) 41 (64.06) 0.6601b
Smoking, no. (%) 30 (42.25) 37 (46.84) 30 (46.88) 0.8188b
BCG vaccination, no. (%) 64 (90.14) 76 (96.20) 56 (87.5) 0.1537b
FIB(g/L) (Mean ± SD) 4.18 ± 1.11 3.82 ± 1.28 3.70 ± 1.15 0.0653a
PT(s) (Mean ± SD) 13.47 ± 1.45 13.15 ± 1.32 13.32 ± 1.27 0.3787a
APTT(s) (Mean ± SD) 31.20 ± 4.39 30.44 ± 4.60 30.27 ± 4.04 0.4464a
TT(s) (Mean ± SD) 14.42 ± 1.32 14.47 ± 1.13 14.78 ± 1.36 0.2483a
Blood glucose (mmol/L) (Mean ± SD) 4.90 ± 0.64 5.04 ± 0.55 5.11 ± 1.74 0.5184a
ESR (mm/h) (Mean ± SD) 11.15 ± 4.85 12.06 ± 5.91 13.72 ± 6.72 0.0388*a
11.63 ± 5.44 13.72 ± 6.72 0.0178*a
CT scan
Degenerative lesions: cavity, caseous necrosis 18 (25.35) 35 (44.30) 20 (31.25) 0.0427*b
Proliferative lesions 29 (40.85) 21 (26.58) 18 (28.13) 0.1307b
Exudation and other inflammatory lesions 21 (29.58) 20 (25.32) 17 (26.56) 0.8365b
Millet lesions 1 (1.41) 0 (0) 7 (10.94) 0.0013**b
Pleural lesion 2 (2.82) 3 (3.80) 2 (3.13) 0.9419b
aP-value between TB cases with PYD, HFYD and DQY Syndromes for one-way ANOVA following Tukey post-hoc test
bP-value between TB cases with PYD, HFYD and DQY Syndromes for χ2 test
N: number of subjects; ND: not determined. *P < 0.05. **P < 0.01
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to 20 of the most intense multiply charged ions being se-
quentially chosen for MS/MS analysis. The mass range
of product ion spectra was from 100 to 2000 m/z. The
reporting iTRAQ ion intensities (113, 118, 119, and
121 m/z) were sufficiently enhanced for quantification.
Proteins identification, quantification and bioinformatics
analysis
Proteins identified and relatively quantified were per-
formed by Protein Pilot software version 4.2 beta (Applied
Biosystems) and International Protein Index database (ver-
sion 3.87, HUMAN). We set the unused ProtScore >1.3 as
cutoff to minimize false positives. More than 2 peptides
with the 95 % confidence were chosen for quantification.
Peptide quantification was also conducted by Pro Group
algorithm to calculate P value, error factor, the reporter
peak area, and to remove redundant hits. When the
P value <0.05 and the error factor <2, the data was reliable
[29]. Functional annotation and classification of proteins
was analyzed by gene ontology (GO) database. Signaling
pathways were conducted by using KEGG database. The
protein-protein interaction was carried out by STRING
software (http://string-db.org/). The fold changes ratios of
>1.3 (up-regulated proteins) or <0.75 (down-regulated
proteins) were chosen for further research.
ELISA analysis
Differential proteins were measured in 154 TB cases (44
PYD cases, 55 HFYD cases, 55 DQY cases) and 62 healthy
controls (randomly chosen) by ELISA. Human Haptoglo-
bin ELISA kit (Abcam, London, England; the dilution was
1:2000), human IGHG3 ELISA kit (CUSABIO Biotech,
Wuhan, Hubei, China; the dilution factor was 1:5000), and
human GGH ELISA kit (CUSABIO Biotech, Wuhan,
Hubei, China; the sample dilution was 1) were used to per-
form experiment in duplicates in accordance with the
manufacturer’s instructions. The results were further ana-
lyzed by one-way ANOVA following Tukey post-hoc test.
The study samples provided at least 83.57 % power to
identify significant differences between TCM syndromes
at a statistical support level of α = 0.05 with an effect
size of 0.6 applying a two tails model calculated by
Gpower3.0.5.
Results
Clinical and pathological analysis of Pulmonary TB cases
The demographic characteristics of the TB patients,
treated-TB patients and healthy controls are shown in
Table 1. There were no significant differences between
the TB patients, treated-TB patients, and healthy con-
trols. The clinical symptoms and signs of TB cases
with PYD, HFYD and DQY syndromes are described
in Additional file 1. Statistical analysis was conducted
by using GraphPad Prism software for the 71 PYD, 79
HFYD, and 64 DQY cases. CT scan findings could be di-
vided into hyperplastic pulmonary lesions (tuberculous
nodules, patch, stripping shadows), degenerative pulmon-
ary lesions (empty and caseous necrotic changes), inflam-
matory lesions with leakages (flake, flocculent shadow and
chronic inflammatory changes), pleural pulmonary lesions
(pleural thickening and pleural effusion), and miliary TB.
Chi-square analysis revealed that PYD cases had tubercu-
lous nodules, patch and stripping shadows. HFYD cases
were identified as having more degenerative pulmonary le-
sions, compared with the PYD and DQY cases. DQY cases
had multiple pulmonary lesion areas with mixed pulmonary
lesions and showed highest incidence of miliary TB, com-
pared with the PYD and HFYD cases (Table 2, Fig. 2a−c).
One-way ANOVA demonstrated that the ESR values were
11.15 ± 4.85 in PYD; 12.06 ± 5.91 in HFYD, and 13.71 ±
6.71 in DQY (P = 0.0388). Surprisingly, the ESR value was
significantly higher in DQY, compared to the PYD and
HFYD (P = 0.0178). The ESR value in HFYD was between
PYD and DQY (Table 2, Fig. 2d).
TCM transformation of TB cases
One-way ANOVA analysis of the 36 treated pulmonary
TB cases revealed that after two to six months of treat-
ment, 94.44 % (12 PYD, 18 HFYD, and 4 DQY before
anti-TB treatment) of 36 treated TB cases were trans-
formed to PYD accompanied with the reduction of ESR
and absorption of pulmonary lesions. The ESR value was
7.70 ± 3.45, significantly lower than the ESR value of
pre-treated cases (P < 0.0001), and the pulmonary cavity
lesions were apparently absorbed and closed. However,
5.56 % of the cases (2 cases) were transformed into
HFYD syndrome. The lesions were absorbed, but the
pulmonary cavity lesions were not closed.
Proteins identification and relative quantification
All iTRAQ labeled proteins were identified and relatively
quantified. A total of 320 proteins were quantified two
times in run 1 and run 2, with the unused ProtScore >1.3,
error factor <2, and P < 0.05. The representative MS/MS
spectrum of one peptide (DTLMISR) of IGHG3 protein is
shown in Fig. 3. Among the 320 proteins, 116 proteins
were identified in PYD with 64 up-regulated and 52
down-regulated proteins, and 108 proteins were identified
in HFYD with 63 up-regulated and 54 down-regulated
proteins. There were 96 proteins acquired in DQY with 51
up-regulated and 45 down-regulated proteins.
Bioinformatic analysis
For the statistical analysis among the three TCM syn-
dromes, 39 differentially expressed proteins were found in
the current study (Additional file 2). All these proteins
were either over expressed (>1.3) or under expressed
(<0.75) when compared with the healthy controls. GO
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analysis showed broad functional distribution for the 320
proteins, with the most frequently used categories of bio-
logical process, cellular component, and molecular func-
tion. It is indicated that most of the differential proteins
were involved in the biological process of biological
regulation (27.69 %), cellular process (19.15 %), response
to stimulus (14.40 %), metabolic process (10.62 %), and
immune system process (6.48 %). Notably, most over-
expressed proteins of HFYD cases were involved in the
immune system process (e.g., LAC2, IGHG3, IGHM,
IGHA1, and IGLL5). In addition, most of the differentially
expressed proteins were located in cell part (36.15 %) and
extracellular region part (21.81 %). The analysis of mo-
lecular function suggested that most of the differentially
expressed proteins have a role in binding (69.61 %) and
catalytic activity (11.94 %) (Fig. 4). KEGG analysis indi-
cated that the differential proteins participated in the
complement clotting chain reaction (Additional file 3).
Furthermore, by using functional network diagram ana-
lysis (STRING), it was found that 39 chosen proteins were
involved in functional and physical connections (Fig. 4d).
Verification of differentially expressed proteins by ELISA
By combining the differentially expressed protein ratios
and bioinformatic analysis of GO, KEGG and STRING,
significantly different proteins (ratios of >1.3 or <0.75)
were chosen for ELISA analysis. All the proteins such as
GGH, IGHG3 and HPT were closely related to the
body’s metabolism, immune function and pulmonary
TB. One-way ANOVA of the ELISA results showed a
significant GGH increase in PYD cases compared with
the healthy controls (P < 0.01, Fig. 5a). In HFYD cases,
IGHG3 was significantly higher than the healthy con-
trols (P < 0.001, Fig. 5b). In DQY cases, HPT was signifi-
cantly higher than the healthy controls (P < 0.01, Fig. 5c).
Comparisons between the three TCM syndromes revealed
significant differences between GGH and IGHG3. GGH
was significantly over-expressed in PYD cases compared
with HFYD and DQY cases (P < 0.01, P < 0.001, respect-
ively) (Fig. 5a). IGHG3 was specifically over-expressed
in HFYD patients compared with PYD and DQY pa-
tients (P < 0.001, P < 0.01, respectively) (Fig. 5b).
Discussion
We have studied the serum proteomics of TB cases with
PYD, HFYD and DQY syndromes by SELDI–TOF MS
combined with weak cation exchange (WCX) magnetic
beads. However, a large amount of proteins cannot be
screened and only one identified protein was acquired fi-
nally due to the limitation of the technology. The clinical
Fig. 2 Radiographic CT findings and ESR analysis of pulmonary TB patients. a CT scan showing tubercular nodules (proliferative lesions); b CT
scan showing pulmonary cavity and tubercular nodules (degenerative lesions and proliferative lesions); c CT scan showing multiple lesions
including proliferative tuberculous nodules and fibroplastic pathological changes. d ESR characteristics of PYD, HFYD, DQY, and the transformed
PYD patients. PYD: pulmonary Yin deficiency syndrome; HFYD: hyperactivity of fire due to Yin deficiency syndrome; DQY: deficiency of Qi and Yin
syndrome; transformed PYD: TB patients who transformed to PYD syndrome after treatment. *P < 0.05, **P < 0.01, ***P < 0.001
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and pathological analysis of PYD, HFYD and DQY cases
was not sufficient [30]. We have also explored the specific-
ally expressed serum proteins in TB patients by iTRAQ-
2DLC-MS/MS, and found serum protein S100A9, SOD3,
and MMP9 as new potential diagnostic biomarkers for
pulmonary TB [31]. We applied the iTRAQ-2DLC-MS/
MS technique to screen specifically expressed serum pro-
teins in TB patients with distinctive TCM syndromes, and
performed clinical and pathological analysis of specifically
expressed proteins by bioinformatic methods.
Pulmonary TB occurs because of the disturbed balance
between Yin and Yang [24]. Patients infected with Myco-
bacterium had Yin deficiency syndrome. With the pro-
gress of the disease, patients had severe imbalance in
Yin-Yang, gradually leading to PYD and HFYD syn-
dromes, and later on to the DQY syndrome. For those
reaching the final stage of DYY syndrome, the patients
were almost in dead condition.
Clinical and pathological analysis
The clinical and pathological analysis showed that PYD
cases basically had hyperplastic lesions, suggesting mild
pathological changes. There were significantly more de-
generative pulmonary lesions in the HFYD cases, com-
pared with PYD and DQY cases. Degenerative lesions
were due to the strong delayed-type hypersensitivity
(DTH), indicating allergic reaction [32]. However, DQY
cases have multiple lesions, often accompanied by a var-
iety of pathological changes, including miliary lesions that
was much higher than the PYD and HFYD cases (P =
0.0013), suggesting severe TB.
The ESR value in the TB cases showed an interesting
phenomenon: it was significantly higher in DQY pa-
tients, compared to the PYD and HFYD patients (P =
0.0178, Table 2, Fig. 2d). ESR could reflect TB severity.
The higher the ESR value, the severe the pathological
stages of TB. In the late pulmonary TB stages, ESR
reached the highest [33, 34]. So, the DQY syndrome be-
longs to the most severe stage with highest ESR value
among the syndromes. Thus, it is believed that TCM
syndromes of TB may be closely related to the ESR and
pathological lesions.
The results revealed that 94.44 % of 36 treated TB
cases (12 PYD, 18 HFYD, and 4 DQY before anti-TB
Fig. 3 The representative MS/MS spectrum showed one of the peptides of IGHG3 protein. a The ion assignments were: 113-healthy control,
118-PYD syndrome, 119-HFYD syndrome, 121-DQY syndrome (114, 115, 116, 117 were for other diseases which were not included in this
research). The intensity of ions from precursor peptides indicated protein expression levels. b The intensity of ions in MS/MS spectra showed
identified peptide sequences with DTLMISR of IGHG3 protein
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treatment) were transformed into PYD with obvious TB
lesion absorption, closing of the pulmonary cavity le-
sions, negative sputum smear/culture and improved
physical signs, and significantly reduced ESR, compared
with the pre-treatment cases. Only 5.56 % of the cases (2
cases) showed HFYD syndrome, and the pulmonary cav-
ity remained unclosed. The ESR reduced, but with no
statistical significance due to the few case numbers. All
the data pointed to the fact that the treatment changed
the TCM syndromes to PYD with improved signs and
symptoms.
The current study employed healthy donors with bal-
anced Yin-Yang as the controls. Serum proteomics was
investigated in the three TCM syndromes by iTRAQ-
2DLC-MS/MS. The results showed that TCM syn-
dromes were mostly associated with GGH, IGHG3, and
HPT proteins. GGH was specifically over-expressed in
the PYD syndrome involved in the metabolism; IGHG3
was significantly over-expressed in the HFYD syndrome
for the immune status; and HPT was specifically over-
expressed in the DQY syndrome participating in the bio-
logical regulations. We suggested that all these proteins
may be involved in the TB pathogenesis with close cor-
relation to the TCM syndromes. ELISA analysis sup-
ported the serum proteomics findings.
GGH was associated with PYD syndrome of Pulmonary TB
The results showed that GGH in the PYD cases was
significantly higher than the healthy controls. GGH
could yield pteroyl-alpha- glutamate (folate) and free
glutamate through hydrolysis, and exert an important
role in the bioavailability of dietary pteroylpolygluta-
mates and in the metabolism of pteroylpolyglutamates
and antifolates [35, 36]. The change in serum GGH
concentration could also change the intracellular or
extracellular folate concentration [37]. Folate is neces-
sary for the survival and toxicity of Mycobacterium. It
is also an important cofactor for DNA synthesis and
repair during Mycobacterium proliferation [38, 39].
Mycobacterium must synthesize folate themselves, be-
cause they could not use the exogenous folate directly.
The host could provide materials for the folate synthe-
sis. So, we speculate that GGH may affect the folic
acid intake of Mycobacterium by affecting the body’s
folate metabolism. In PYD cases, when GGH in-
creased, the body could make better use of the folate
from food. Excessive folate can produce more glutam-
ate and para-aminobengoic acid as synthesizing mater-
ial for the folate synthesis. It was also found that GGH
in PYD cases was much higher than in the HFYD and
DQY cases, indicating that folate was most effectively
Fig. 4 Data mining of differentially expressed proteins. a Biological process. b Cellular component. c Molecular function. d Functional network of
differentially expressed proteins
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used in PYD cases. Thus, serum GGH may be associ-
ated with folic acid intake of Mycobacterium in PYD
patients.
IGHG3 was associated with HFYD syndrome of Pulmonary
TB
In this study, IGHG3 in the HFYD cases was signifi-
cantly higher than the healthy controls. IGHG3 could
bind with IgG Fc receptor (FcγR) of neutrophilic gran-
ulocyte and macrophages, thereby promoting phagocyt-
osis and controlling the infection [40]. IGHG3 could
also combine with FcγRI on the surface of dendritic cells
with high affinity, and enhance the antigen presentation
function of dendritic cells to T lymphocyte [41–43]. Ele-
vated serum IGHG3, on the one hand could combine
with FcγR, mediate the macrophage phagocytosis, and
control the infection. On the other hand, increased
IGHG3 could be combined with FcγRI so as to increase
the antigen presenting function of dendritic cells. It was
also observed that IGHG3 in the HFYD cases were
much higher than the PYD and DQY cases. The current
results suggested that IGHG3 may be associated with
the control of Mycobacterium infection in HFYD pa-
tients. In clinical practice, HFYD has obvious symptoms
of internal fire due to Yin deficiency, presenting fever,
while in PYD and DQY cases, fever signs were not so
evident. The relationship between IGHG3 and the in-
ternal fire of HFYD syndrome need further research.
HPT was associated with DQY syndrome of Pulmonary TB
In this experiment, HPT in the DQY cases was signifi-
cantly higher than the healthy controls. HPTcould capture
and combine with free hemoglobin, while hemoglobin
could carry oxygen from the lung surface to the aerobic
tissues. In clinical practice DQY patients have obvious
symptoms of hypoxia, such us cyanosis. Hypoxia is seque-
lae of TB and concomitant pulmonary diseases [44]. TB
may even lead to respiratory distress syndrome with more
severe hypoxia [45, 46]. When the tissue is in a state of
hypoxia, it will increase the oxygen demand and change
the hemoglobin by configuration so as to improve the oxy-
gen usage [47]. But increased hemoglobin could promote
the production of oxygen radicals, leading to oxidative
damage and cell death [48–50]. HPT can combine with
hemoglobin so as to stop the production of oxygen rad-
icals in the blood and its toxic effects [51, 52]. While in
PYD and HFYD cases, its value was between the
healthy controls and DQY cases. The results were in
correspondence with the clinical syndromes and TCM
theories of TB cases. Increased HPT may indicate
Fig. 5 Analysis of differentially expressed proteins by ELISA and one-way ANOVA. a GGH; b IGHG3; c HPT. PYD: pulmonary Yin deficiency syndrome;
HFYD: hyperactivity of fire due to Yin deficiency syndrome; DQY: deficiency of Qi and Yin syndrome; GGH: gamma-glutamyl hydrolase; IGHG3: Ig
gamma-3 chain C region; HPT: haptoglobin. *P < 0.05, **P < 0.01, ***P < 0.001
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hypoxic condition and was closely associated with the
DQY syndrome in TB patients.
In order to amplify the value of our study, a larger
number of TB patients with DYY syndrome should be
further tested. Further studies with treated patients are
needed to confirm the importance of these results as po-
tential biomarkers of PYD, HFYD and DQY syndromes.
Conclusions
To sum up, TCM syndromes classification in pulmonary
TB cases were closely related to the clinical and patho-
logical changes and ESR. After treatment, most cases
were transformed into PYD syndrome. Serum proteins
such as GGH, IGHG3 and HPT were specifically over-
expressed in PYD, HFYD, and DQY patients, respect-
ively. GGH was associated with folate metabolism in
PYD patients, and IGHG3 was linked to the control of
Mycobacterium infection in HFYD patients. However,
HPT was involved in hypoxia in DQY patients. The re-
sults provide clinical evidence and experimental basis
for TCM syndromes of pulmonary TB. In addition, the
data laid biological basis for the TCM syndromes classi-
fication, especially, providing an important clue for
TCM differential diagnosis with improved and important
scientific significance.
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